Faeth Therapeutics
PrivateLast Round
Private Placement
Feb 18, 2026
Total Funding Raised
$92M
Momentum Score
25 /100
Company Overview
Faeth is a healthcare company that leverages data-driven insights to tailor specific diets to tumor genotypes and treatment plans, aiming to restrict the energy and resources tumors need to thrive in cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Faeth Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Faeth Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Feb 18, 2026 | ||||
| Strategic | Oct 20, 2025 | ||||
| Series A | Jun 30, 2022 | ||||
| Seed | Jan 18, 2022 |
Key People
Founding team and executive leadership
Faeth Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balyasny Asset Management L.P. | Private Placement |
| RA Capital Management | Private Placement |
| Future Ventures | Series A, Strategic, Seed |
| Fairmount Funds Management | Private Placement |
| Digitalis Ventures | Strategic |
| B Capital Group | Strategic |
| Khosla Ventures | Series A, Strategic, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Open roles increased to 15, 2.4x the trailing average.
- May 11, 2026
Open roles increased to 13, 46% of headcount.
Faeth Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Faeth Therapeutics's valuation, stock price, and market status.
